ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · IEX Real-Time Price · USD
6.72
-0.35 (-4.95%)
At close: Apr 18, 2024, 4:00 PM
6.67
-0.05 (-0.74%)
Pre-market: Apr 19, 2024, 8:00 AM EDT
ESSA Pharma Market Cap
ESSA Pharma has a market cap or net worth of $297.28 million as of April 19, 2024. Its market cap has increased by 145.08% in one year.
Market Cap
297.28M
Enterprise Value
155.28M
1-Year Change
145.08%
Ranking
Category
Stock Price
$6.72
Market Cap Chart
Since March 31, 2015, ESSA Pharma's market cap has increased from $146.10M to $297.28M, an increase of 103.48%. That is a compound annual growth rate of 8.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 297.30M | -4.96% |
Apr 17, 2024 | 312.80M | -4.84% |
Apr 16, 2024 | 328.70M | 1.80% |
Apr 15, 2024 | 322.90M | -5.94% |
Apr 12, 2024 | 343.30M | -5.95% |
Apr 11, 2024 | 365.00M | 5.25% |
Apr 10, 2024 | 346.80M | 1.40% |
Apr 9, 2024 | 342.00M | -7.19% |
Apr 8, 2024 | 368.50M | -0.59% |
Apr 5, 2024 | 370.70M | 2.69% |
Apr 4, 2024 | 361.00M | 2.01% |
Apr 3, 2024 | 353.90M | -2.45% |
Apr 2, 2024 | 362.80M | -2.60% |
Apr 1, 2024 | 372.50M | -0.83% |
Mar 28, 2024 | 375.60M | -0.82% |
Mar 27, 2024 | 378.70M | -3.27% |
Mar 26, 2024 | 391.50M | -2.10% |
Mar 25, 2024 | 399.90M | 0.10% |
Mar 22, 2024 | 399.50M | -1.72% |
Mar 21, 2024 | 406.50M | -0.12% |
Mar 20, 2024 | 407.00M | -1.07% |
Mar 19, 2024 | 411.40M | 2.19% |
Mar 18, 2024 | 402.60M | 1.13% |
Mar 15, 2024 | 398.10M | 1.12% |
Mar 14, 2024 | 393.70M | -1.55% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lyra Therapeutics | 322.91M |
Renovaro Biosciences | 318.94M |
Fractyl Health | 317.91M |
SOPHiA GENETICS | 316.71M |
Esperion Therapeutics | 313.57M |
Atea Pharmaceuticals | 312.25M |
AirSculpt Technologies | 310.65M |
FibroBiologics | 310.50M |